In silico models of cancer
- PMID: 20836040
- PMCID: PMC3157287
- DOI: 10.1002/wsbm.75
In silico models of cancer
Abstract
Cancer is a complex disease that involves multiple types of biological interactions across diverse physical, temporal, and biological scales. This complexity presents substantial challenges for the characterization of cancer biology, and motivates the study of cancer in the context of molecular, cellular, and physiological systems. Computational models of cancer are being developed to aid both biological discovery and clinical medicine. The development of these in silico models is facilitated by rapidly advancing experimental and analytical tools that generate information-rich, high-throughput biological data. Statistical models of cancer at the genomic, transcriptomic, and pathway levels have proven effective in developing diagnostic and prognostic molecular signatures, as well as in identifying perturbed pathways. Statistically inferred network models can prove useful in settings where data overfitting can be avoided, and provide an important means for biological discovery. Mechanistically based signaling and metabolic models that apply a priori knowledge of biochemical processes derived from experiments can also be reconstructed where data are available, and can provide insight and predictive ability regarding the behavior of these systems. At longer length scales, continuum and agent-based models of the tumor microenvironment and other tissue-level interactions enable modeling of cancer cell populations and tumor progression. Even though cancer has been among the most-studied human diseases using systems approaches, significant challenges remain before the enormous potential of in silico cancer biology can be fully realized.
Figures





Similar articles
-
In silico cancer research towards 3R.BMC Cancer. 2018 Apr 12;18(1):408. doi: 10.1186/s12885-018-4302-0. BMC Cancer. 2018. PMID: 29649981 Free PMC article. Review.
-
Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):253-76. doi: 10.1080/10937404.2010.483943. J Toxicol Environ Health B Crit Rev. 2010. PMID: 20574901
-
Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery.BMC Syst Biol. 2007 Feb 15;1:13. doi: 10.1186/1752-0509-1-13. BMC Syst Biol. 2007. PMID: 17408503 Free PMC article.
-
Proteomic and computational methods in systems modeling of cellular signaling.Curr Pharm Biotechnol. 2006 Jun;7(3):135-45. doi: 10.2174/138920106777549722. Curr Pharm Biotechnol. 2006. PMID: 16789899 Review.
-
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2. Phys Biol. 2013. PMID: 23912807
Cited by
-
Genetic interaction networks: better understand to better predict.Front Genet. 2013 Dec 17;4:290. doi: 10.3389/fgene.2013.00290. Front Genet. 2013. PMID: 24381582 Free PMC article. Review.
-
Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma.Front Oncol. 2020 Jan 22;9:1443. doi: 10.3389/fonc.2019.01443. eCollection 2019. Front Oncol. 2020. PMID: 32038993 Free PMC article. Review.
-
Simulation of the Protein-Shedding Kinetics of a Fully Vascularized Tumor.Cancer Inform. 2015 Dec 20;14:163-75. doi: 10.4137/CIN.S35374. eCollection 2015. Cancer Inform. 2015. PMID: 26715830 Free PMC article.
-
Simulating cancer growth with multiscale agent-based modeling.Semin Cancer Biol. 2015 Feb;30:70-8. doi: 10.1016/j.semcancer.2014.04.001. Epub 2014 May 2. Semin Cancer Biol. 2015. PMID: 24793698 Free PMC article. Review.
-
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks.Genome Med. 2012 Feb 24;4(2):16. doi: 10.1186/gm315. Genome Med. 2012. PMID: 22364233 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000;100(1):57–70. - PubMed
-
- Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 1983;304(5927):596–602. - PubMed
-
- Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 1997;11(5):663–677. - PubMed
-
- Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 1992;359(6395):554–556. - PubMed
-
- Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;432(7015):307–15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources